We use cookies and other tracking technologies to improve your browsing experience on our website, to show you personalized content and targeted ads, to analyze our website traffic, and to understand ...

The two simultaneous Incyte trials in HS saw more than 40% of patients on povorcitinib achieving a clinical response.

The proceeds from the issue of shares will be used to accelerate the commercialisation of the Company's novel and innovative oral iron supplement, Iron Hydroxide Adipate Tartrate ("IHAT"), the ...

You probably think about what and how much you throw away – but do you ever stop to think about what you throw it into? If ...

DUBLIN, IE / ACCESS Newswire / March 14, 2025 / Nemysis is pleased to announce signing of a Distribution and Supply Agreement (the “Agreement”) for its unique oral iron supplement, Iron Hydroxide ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

D printing of tubular biocomposites reveals moisture-sensitive actuators, offering insights into programmable materials for environmental responsiveness.